Table 3.
Prevalence | |||||
NCEP 2004 n = 156 |
NCEP 2001 n = 149 |
WHO n = 70 |
IDF n = 159 |
EGIR n = 47 |
|
Age < 40 years n (%) | 2 (0.5) | 2 (0.5) | 2 (0.6) | 3 (0.9) | 0 (0) |
Age 40 to 49 years n (%) | 12 (3.1) | 12 (3.1) | 4 (1.1) | 12 (3.4) | 0 (0) |
Age 50 to 59 years n (%) | 32 (8.2) | 29 (7.5) | 15 (4.2) | 32 (9.1) | 12 (3.1) |
Age ≥ 60 years n (%) | 110 (28.3) | 106 (27.2) | 49 (13.6) | 112 (31.9) | 35 (9.0) |
EGIR = European Group for Insulin Resistance; IDF = International Diabetes Federation; NCEP = National Cholesterol Education Programme; WHO = World Health Organization.